Read the digital edition of CHEManager International. Simply enter the subscription number or promotional code and login. You will find your subscription number on your invoice, or a previous print edition. The promotional code is '247'.
09.06.2020
- Anglo-Swedish drugmaker AstraZeneca is weighing a merger with US biotech Gilead Sciences, the Bloomberg news agency has reported. Surpassing Bristol Myers Squibb’s $74 billion...
09.06.2020
- Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...
08.06.2020
- With national governments racing to nail down doses of a Covid-19 vaccine – when it comes – for their own populations, the EU’s leadership is keen to make sure that its own...
05.06.2020
- Gilead Sciences has entered a 10-year partnership with oncology-focused biopharma Arcus Biosciences to develop and commercialize current and future therapeutic candidates in Arcus...
05.06.2020
- GlaxoSmithKline (GSK) has agreed to make 1 billion doses of its AS03 adjuvant available to several developers of Covid-19 vaccines and plans to increase capacity to supply enough...
03.06.2020
- Novartis's gene therapy unit AveXis has signed an agreement to produce a novel genetic COVID-19 vaccine being developed by the US-based Mass General Brigham health care system...
01.06.2020
- German Contract Development & Manufacturing Organization CordenPharma has expanded its strategic manufacturing services agreement with Moderna to include the supply of lipid...
28.05.2020
- US pharma giant Merck & Co is wading into the race to find a vaccine or treatment for Covid-19. The New Jersey-based company is joining forces with nonprofit research group IAVI on...
